©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 14, 2016; 22(34): 7760-7766
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7760
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7760
Long-term outcomes of autoimmune pancreatitis
Tsukasa Ikeura, Hideaki Miyoshi, Masaaki Shimatani, Kazushige Uchida, Makoto Takaoka, Kazuichi Okazaki, Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan
Author contributions: Ikeura T, Miyoshi H and Shimatani M wrote the manuscript; Uchida K and Takaoka M made revision of the manuscript; Okazaki K made final approval of the manuscript to be published.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Correspondence to: Tsukasa Ikeura, MD, PhD, Department of Gastroenterology and Hepatology, Kansai Medical University, 2-3-1, Shinmachi, Hirakata, Osaka 573-1010, Japan. ikeurat@hirakata.kmu.ac.jp
Telephone: +81-72-8040101 Fax: +81-72-8042534
Received: March 28, 2016
Peer-review started: March 31, 2016
First decision: May 12, 2016
Revised: June 4, 2016
Accepted: June 28, 2016
Article in press: June 29, 2016
Published online: September 14, 2016
Processing time: 163 Days and 19.2 Hours
Peer-review started: March 31, 2016
First decision: May 12, 2016
Revised: June 4, 2016
Accepted: June 28, 2016
Article in press: June 29, 2016
Published online: September 14, 2016
Processing time: 163 Days and 19.2 Hours
Core Tip
Core tip: There is limited information on long-term outcomes of patients with autoimmune pancreatitis (AIP). This review provides a current overview of AIP regarding long-term outcomes such as pancreatic stone formation, pancreatic exocrine or endocrine dysfunction, associated malignancy, and mortality.